Quercetin and sesamin protect dopaminergic cells from MPP +-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Bournival, Julie ^a,b   Plouffe, Marilyn ^a   Renaud, Justine ^a   Provencher, Cindy ^a   Martinoli, Maria Grazia ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1-METHYL-4-PHENYLPYRIDINIUM; ANTI-INFLAMMATORIES; APOPTOTIC; CO-CULTURE SYSTEM; CYTOKINES; ENZYME-LINKED IMMUNOABSORBENT ASSAYS; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMATORY MEDIATORS; INTERLEUKIN-6; MICROGLIA; MICROGLIAL CELLS; MITOCHONDRIAL SUPEROXIDE; NEUROINFLAMMATION; NEURONAL CELL; PARKINSONS DISEASE; PC12 CELLS; PHYTOESTROGENES; PROTEIN EXPRESSIONS; PROTEIN LEVEL; SESAMIN; TUMOR NECROSIS FACTOR-ALPHA;

CELL DEATH; MOLECULES; NEURONS; NITRIC OXIDE; OXYGEN; PHENOLS; POLYMERASE CHAIN REACTION; SELF ASSEMBLY;

FATTY ACIDS;

1 METHYL 4 PHENYLPYRIDINIUM; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; QUERCETIN; SESAMIN; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; 1,3 DIOXOLANE DERIVATIVE; CYTOKINE; LIGNAN; NEUROPROTECTIVE AGENT;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN; COCULTURE; CYTOKINE PRODUCTION; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; MACROPHAGE ACTIVATION; MICROGLIA; MITOCHONDRION; NERVE CELL; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL PROTECTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; KINETICS; METABOLISM; MOUSE; PATHOLOGY; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; COCULTURE TECHNIQUES; CYTOKINES; CYTOPROTECTION; DIOXOLES; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION; INFLAMMATION; KINETICS; LIGNANS; MICE; MICROGLIA; MITOCHONDRIA; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PC12 CELLS; QUERCETIN; RATS; RNA, MESSENGER; SUPEROXIDES;

EID: 84864951956     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/921941     Document Type: Article

References (61)

1. McGeer P. L., McGeer E. G., Glial reactions in Parkinson's disease Movement Disorders 2008 23 4 474 483
2. Frankola K. A., Greig N. H., Luo W., Tweedie D., Stargeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases CNS and Neurological Disorders 2011 10 3 391 403
3. Qian L., Flood P. M., Hong J. S., Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy Journal of Neural Transmission 2010 117 8 971 979
4. Ouchi Y., Yagi S., Yokokura M., Sakamoto M., Neuroinflammation in the living brain of Parkinson's disease Parkinsonism and Related Disorders 2009 15 3 S200 S204
5. Mirza B., Hadberg H., Thomsen P., Moos T., The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease Neuroscience 1999 95 2 425 432
6. Hirsch E. C., Hunot S., Neuroinflammation in Parkinson's disease: a target for neuroprotection? The Lancet Neurology 2009 8 4 382 397
7. Lawson L. J., Perry V. H., Dri P., Gordon S., Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain Neuroscience 1990 39 1 151 170
8. Kim W. G., Mohney R. P., Wilson B., Jeohn G. H., Liu B., Hong J. S., Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia Journal of Neuroscience 2000 20 16 6309 6316 (Pubitemid 30658427)
9. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debré P., Agid Y., Dugas B., Hirsch E. C., Fc RII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor- in glial cells Journal of Neuroscience 1999 19 9 3440 3447 (Pubitemid 29203124)
10. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., Nagatsu T., Interleukin (IL)-1, IL-2, IL-4, IL-6 and transforming growth factor- levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease Neuroscience Letters 1996 211 1 13 16 (Pubitemid 26228016)
11. Kohutnicka M., Lewandowska E., Kurkowska-Jastrzbska I., Czonkowski A., Czonkowska A., Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Immunopharmacology 1998 39 3 167 180 (Pubitemid 28432061)
12. Czonkowska A., Kohutnicka M., Kurkowska-Jastrzbska I., Czonkowski A., Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model Neurodegeneration 1996 5 2 137 143 (Pubitemid 26248603)
13. Sriram K., Miller D. B., O'Callaghan J. P., Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- Journal of Neurochemistry 2006 96 3 706 718
14. Segura-Aguilar J., Kostrzewa R. M., Neurotoxins and neurotoxic species implicated in neurodegeneration Neurotoxicity Research 2004 6 7-8 615 630
15. Zhang Y., Dawson V. L., Dawson T. M., Oxidative stress and genetics in the pathogenesis of parkinson's disease Neurobiology of Disease 2000 7 4 240 250
16. Obata T., Nitric oxide and MPP + -induced hydroxyl radical generation Journal of Neural Transmission 2006 113 9 1131 1144 (Pubitemid 44291009)
17. Langston J. W., Forno L. S., Tetrud J., Reeves A. G., Kaplan J. A., Karluk D., Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Annals of Neurology 1999 46 4 598 605 (Pubitemid 29466438)
18. Barcia C., De Pablos V., Bautista-Hernndez V., Snchez-Bahillo., Bernal I., Fernndez-Villalba E., Martn J., Ban R., Fernndez-Barreiro A., Herrero M. T., Increased plasma levels of TNF- but not of IL1- in MPTP-treated monkeys one year after the MPTP administration Parkinsonism and Related Disorders 2005 11 7 435 439 (Pubitemid 41526994)
19. Zhao C., Ling Z., Newman M. B., Bhatia A., Carvey P. M., TNF- knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice Neurobiology of Disease 2007 26 1 36 46 (Pubitemid 46437443)
20. Lakshmanan A. P., Watanabe K., Thandavarayan R. A., Sari F. R., Meilei H., Soetikno V., Arumugam S., Giridharan V. V., Suzuki K., Kodama M., Curcumin attenuates hyperglycaemia-mediated AMPK activation and oxidative stress in cerebrum of streptozotocin-induced diabetic rat Free Radical Research 2011 45 7 788 795
21. Zhang M., Swarts S. G., Yin L., Liu C., Tian Y., Cao Y., Swarts M., Yang S., Zhang S. B., Zhang K., Ju S., Olek Jr. D. J., Schwartz L., Keng P. C., Howell R., Zhang L., Okunieff P., Antioxidant properties of quercetin Advances in Experimental Medicine and Biology 2011 701 283 289
22. Singh M., Arseneault M., Sanderson T., Murthy V., Ramassamy C., Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms Journal of Agricultural and Food Chemistry 2008 56 13 4855 4873 (Pubitemid 352039080)
23. Pandey K. B., Rizvi S. I., Plant polyphenols as dietary antioxidants in human health and disease Oxidative Medicine and Cellular Longevity 2009 2 5 270 278
24. Mercer L. D., Kelly B. L., Horne M. K., Beart P. M., Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures Biochemical Pharmacology 2005 69 2 339 345 (Pubitemid 41556580)
25. Bournival J., Quessy P., Martinoli M. G., Protective effects of resveratrol and quercetin against MPP + -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons Cellular and Molecular Neurobiology 2009 29 8 1169 1180
26. Bureau G., Longpré F., Martinoli M. G., Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation Journal of Neuroscience Research 2008 86 2 403 410 (Pubitemid 351196745)
27. Kao T. K., Ou Y. C., Raung S. L., Lai C. Y., Liao S. L., Chen C. J., Inhibition of nitric oxide production by quercetin in endotoxin/cytokine- stimulated microglia Life Sciences 2010 86 9-10 315 321
28. Shahidi F., Wanasundara P. K., Phenolic antioxidants Critical Reviews in Food Science and Nutrition 1992 32 1 67 103
29. Hirata F., Fujita K., Ishikura Y., Hosoda K., Ishikawa T., Nakamura H., Hypocholesterolemic effect of sesame lignan in humans Atherosclerosis 1996 122 1 135 136 (Pubitemid 26132629)
30. Lee C. C., Chen P. R., Lin S., Tsai S. C., Wang B. W., Chen W. W., Tsai C. E., Shyu K. G., Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implications for its antihypertensive effect Journal of Hypertension 2004 22 12 2329 2338 (Pubitemid 39620283)
31. Noguchi T., Ikeda K., Sasaki Y., Yamamoto J., Seki J., Yamagata K., Nara Y., Hara H., Kakuta H., Yamori Y., Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats Hypertension Research 2001 24 6 735 742 (Pubitemid 33133790)
32. Lahaie-Collins V., Bournival J., Plouffe M., Carange J., Martinoli M. G., Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP + -induced oxidative stress Oxidative Medicine and Cellular Longevity 2008 1 1 54 62
33. Gélinas S., Martinoli M. G., Neuroprotective effect of estradiol and phytoestrogens on MPP + -induced cytotoxicity in neuronal PC12 cells Journal of Neuroscience Research 2002 70 1 90 96
34. Li F. Q., Wang T., Pei Z., Liu B., Hong J. S., Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons Journal of Neural Transmission 2005 112 3 331 347 (Pubitemid 40868048)
35. Martin A., Clynes M., Acid phosphatase: endpoint for in vitro toxicity tests In Vitro Cellular and Developmental Biology 1991 27 3 183 184
36. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biology 2002 3 7 RESEARCH0034
37. Aquilano K., Baldelli S., Rotilio G., Ciriolo M. R., Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols Neurochemical Research 2008 33 12 2416 2426
38. Li Y., Liu L., Barger S. W., Mrak R. E., Griffin W. S. T., Vitamin E suppression of microglial activation is neuroprotective Journal of Neuroscience Research 2001 66 2 163 170 (Pubitemid 32912285)
39. Gille G., Rausch W. D., Hung S. T., Moldzio R., Ngyuen A., Janetzky B., Engfer A., Reichmann H., Protection of dopaminergic neurons in primary culture by lisuride Journal of Neural Transmission 2002 109 2 157 169 (Pubitemid 34185661)
40. Mogi M., Togari A., Ogawa M., Ikeguchi K., Shizuma N., Fan D. S., Nakano I., Nagatsu T., Effects of repeated systemic administration of 1-methyl-4- phenyl1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1 and nerve growth factor in the striatum Neuroscience Letters 1998 250 1 25 28 (Pubitemid 28341768)
41. Hunter R. L., Dragicevic N., Seifert K., Choi D. Y., Liu M., Kim H. C., Cass W. A., Sullivan P. G., Bing G., Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system Journal of Neurochemistry 2007 100 5 1375 1386
42. Liu Y., Qin L., Li G., Zhang W., An L., Liu B., Hong J. S., Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation Journal of Pharmacology and Experimental Therapeutics 2003 305 1 212 218 (Pubitemid 36373853)
43. Liao S. L., Chen W. Y., Chen C. J., Estrogen attenuates tumor necrosis factor- expression to provide ischemic neuroprotection in female rats Neuroscience Letters 2002 330 2 159 162
44. Joglar B., Rodriguez-Pallares J., Rodriguez-Perez A. I., Rey P., Guerra M. J., Labandeira-Garcia J. L., The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease Journal of Neurochemistry 2009 109 2 656 669
45. Villar-Cheda B., Dominguez-Meijide A., Joglar B., Rodriguez-Perez A. I., Guerra M. J., Labandeira-Garcia J. L., Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors Neurobiology of Disease 2012 47 2 268 279
46. Gonzlez-Scarano F., Baltuch G., Microglia as mediators of inflammatory and degenerative diseases Annual Review of Neuroscience 1999 22 219 240 (Pubitemid 29144887)
47. Chen J., Tang X. Q., Zhi J. L., Cui Y., Yu H. M., Tang E. H., Sun S. N., Feng J. Q., Chen P. X., Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway Apoptosis 2006 11 6 943 953 (Pubitemid 43876825)
48. Hou R. C. W., Huang H. M., Tzen J. T. C., Jeng K. C. G., Protective effects of sesamin and sesamolin on hypoxic neuronal and PC12 cells Journal of Neuroscience Research 2003 74 1 123 133 (Pubitemid 37176675)
49. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., Mcauliffe W. G., Dawson V. L., Dawson T. M., Przedborski S., Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nature Medicine 1999 5 12 1403 1409
50. Schaffer S., Halliwell B., Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations Genes and Nutrition 2012 7 2 99 109
51. Clavel T., Doré J., Blaut M., Bioavailability of lignans in human subjects Nutrition Research Reviews 2006 19 2 187 196 (Pubitemid 46213350)
52. Ross J. A., Kasum C. M., Dietary flavonoids: bioavailability, metabolic effects, and safety Annual Review of Nutrition 2002 22 19 34 (Pubitemid 35221452)
53. Papadakis E. N., Lazarou D., Grougnet R., Magiatis P., Skaltsounis A. L., Papadopoulou-Mourkidou E., Papadopoulos A. I., Effect of the form of the sesame-based diet on the absorption of lignans British Journal of Nutrition 2008 100 6 1213 1219
54. Fiorani M., Accorsi A., Cantoni O., Human red blood cells as a natural flavonoid reservoir Free Radical Research 2003 37 12 1331 1338 (Pubitemid 37441716)
55. Janle E. M., Lila M. A., Grannan M., Wood L., Higgins A., Yousef G. G., Rogers R. B., Kim H., Jackson G. S., Ho L., Weaver C. M., Pharmacokinetics and tissue distribution of 14C-Labeled grape polyphenols in the periphery and the central nervous system following oral administration Journal of Medicinal Food 2010 13 4 926 933
56. Youdim K. A., Qaiser M. Z., Begley D. J., Rice-Evans C. A., Abbott N. J., Flavonoid permeability across an in situ model of the blood-brain barrier Free Radical Biology and Medicine 2004 36 5 592 604 (Pubitemid 38230176)
57. Faria A., Pestana D., Teixeira D., Couraud P. O., Romero I., Weksler B., De Freitas V., Mateus N., Calhau C., Insights into the putative catechin and epicatechin transport across blood-brain barrier Food and Function 2011 2 1 39 44
58. Scheepens A., Tan K., Paxton J. W., Improving the oral bioavailability of beneficial polyphenols through designed synergies Genes and Nutrition 2010 5 1 75 87
59. Vauzour D., Rodriguez-Mateos A., Corona G., Oruna-Concha M. J., Spencer J. P. E., Polyphenols and human health: prevention of disease and mechanisms of action Nutrients 2010 2 11 1106 1131
60. Khan M. M., Ishrat T., Ahmad A., Hoda M. N., Khan M. B., Khuwaja G., Srivastava P., Raza S. S., Islam F., Ahmad S., Sesamin attenuates behavioral, biochemical and histological alterations induced by reversible middle cerebral artery occlusion in the rats Chemico-Biological Interactions 2010 183 1 255 263
61. Hsieh P. F., Hou C. W., Yao P. W., Wu S. P., Peng Y. F., Shen M. L., Lin C. H., Chao Y. Y., Chang M. H., Jeng K. C., Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epilepticus by inhibition of MAPK and COX-2 activation Journal of Neuroinflammation 2011 8, article 57